We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

57 hedge funds and large institutions have $141M invested in PDS Biotechnology in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 14

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

4% more funds holding

Funds holding: 55 → 57 (+2)

0.07% less ownership

Funds ownership: 2.51% → 2.44% (-0.07%)

15% less capital invested

Capital invested by funds: $166M → $141M (-$25M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
57
Holders Change
+2
Holders Change %
+3.64%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
7
Increased
20
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.76M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$672K
3
EAM
Eagle Asset Management
Florida
+$363K
4
GIP
Granite Investment Partners
California
+$318K
5
State Street
State Street
Massachusetts
+$165K

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$3.11M
2
VMI
VHCP Management II
New York
-$3.06M
3
Millennium Management
Millennium Management
New York
-$430K
4
AllianceBernstein
AllianceBernstein
Tennessee
-$335K
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$247K
Name Holding Trade Value Shares
Change 		Change in
Stake
GIP
26
Granite Investment Partners
California
$296K +$318K +1,581 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$291K – – –
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$273K +$34.2K +170 +13%
DCM
29
DAFNA Capital Management
California
$182K – – –
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$173K +$6.24K +31 +3%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$162K – – –
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$159K -$33.6K -167 -16%
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$141K – – –
TI
34
Trexquant Investment
Connecticut
$132K +$20.1K +100 +17%
AIG
35
American International Group
New York
$125K +$604 +3 +0.5%
WPC
36
White Pine Capital
Minnesota
$109K – – –
SG Americas Securities
37
SG Americas Securities
New York
$103K +$111K +550 New
VOYA Investment Management
38
VOYA Investment Management
Georgia
$96K – – –
Wells Fargo
39
Wells Fargo
California
$94K -$72K -358 -42%
MSFP
40
Mark Sheptoff Financial Planning
Connecticut
$88K -$27.2K -135 -22%
Bank of America
41
Bank of America
North Carolina
$53K +$39.2K +195 +222%
Legal & General Group
42
Legal & General Group
United Kingdom
$52K – – –
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$37.5K +$21.9K +109 +120%
TRCT
44
Tower Research Capital (TRC)
New York
$31K +$4.63K +23 +16%
Barclays
45
Barclays
United Kingdom
$31K +$28K +139 +604%
IA
46
IFP Advisors
Florida
$28K +$30.2K +150 New
Parallax Volatility Advisers
47
Parallax Volatility Advisers
California
$28K +$30.4K +151 New
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$25K -$16.5K -82 -37%
AIP
49
Ameritas Investment Partners
Nebraska
$16K – – –
PCC
50
Park Circle Company
Maryland
$11K – – –
1
2
3

PDSB Hedge Fund Activity: Q4 2017 in Review

57 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q4 2017, worth a combined $141M — down 15% from $166M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new PDSB positions and 5 closed out — a net gain of 2 holders — while 20 added to existing stakes and 14 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $1.76M. The largest seller was Acuta Capital Partners, cutting an estimated $3.11M.

  • 57 institutional investors held PDS Biotechnology (PDSB) as of Q4 2017, up from 55 in Q3 2017.
  • Funds reported $141M of PDS Biotechnology stock for Q4 2017, down 15% quarter-over-quarter.
  • 7 funds opened new PDS Biotechnology positions in Q4 2017 and 5 closed out, a net change of +2 holders.
  • The largest PDS Biotechnology buyer in Q4 2017 was Adage Capital Partners, an estimated $1.76M added.
  • The largest PDS Biotechnology seller in Q4 2017 was Acuta Capital Partners, an estimated $3.11M sold.

Based on aggregated 13F filings for Q4 2017.